← Return to Ivermectin for Prostate Cancer? (Being studied)
DiscussionIvermectin for Prostate Cancer? (Being studied)
Prostate Cancer | Last Active: Sep 6 10:58am | Replies (73)Comment receiving replies
Replies to "You make some really good points . PSA is a predictor of a bunch of things..."
@vancouverislandhiker, thank you for adding "with your doctor's approval". You're also correct that ivermectin and related anti-parasitic medications have been on the market for years. However, this does not make them safe for all conditions.
I add a caution about the statement "trying it can't hurt you." Repurposing drugs for conditions for which they are not approved may be benign (have no effect), cause unwanted symptoms, be irrevesibly harmful or, in some cases, be fatal. So back to your statement about talking with your doctor when considering off-label medications.
I know you guys are going to find me annoying 😁, but I have to repeat the community guidelines https://connect.mayoclinic.org/blog/about-connect/tab/community-guidelines/.
A recap in blunt and brief:
1. Don't prescribe or tell people what to do.
2. Never disregard professional medical advice or delay in seeking it because of something you have read on the community.
3. Keep politics out of the community conversations.
Oh, going overseas to some countries is inviting a parasitic infection, as you point out. I’ve heard some real horror stories!
The reason I don’t do Ivermectin now - besides my belief that it is not proven yet for PCa - is that I am currently on Orgovyx for recurrence with radiation to follow. In just one month my PSA has gone from .18 to .05 and my testosterone from 609 to 5. Five more months can only enhance its ability to starve the cancer cells.
With that kind of result why would I try something that has never been tested in double blind studies? Why add a possible as yet unknown drug interaction? Why fix it if it ain’t broke?
Ivermectin and others surely have promise - I’ve read of their ability to inhibit certain functions in cancer cells of all types; it definitely needs to be explored in greater depth. I have no doubt that if this inexpensive drug could be turned into a multi billion dollar powerhouse, Big Pharma would molecularly tweak it just enough to avoid any patent disputes and sell it like crazy with a catchy name.